M.H. Otten

1.6k total citations
42 papers, 1.1k citations indexed

About

M.H. Otten is a scholar working on Hematology, Rheumatology and Surgery. According to data from OpenAlex, M.H. Otten has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 13 papers in Rheumatology and 12 papers in Surgery. Recurrent topics in M.H. Otten's work include Autoimmune and Inflammatory Disorders Research (16 papers), Adolescent and Pediatric Healthcare (7 papers) and Rheumatoid Arthritis Research and Therapies (7 papers). M.H. Otten is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (16 papers), Adolescent and Pediatric Healthcare (7 papers) and Rheumatoid Arthritis Research and Therapies (7 papers). M.H. Otten collaborates with scholars based in Netherlands, United States and United Kingdom. M.H. Otten's co-authors include Lisette W. A. van Suijlekom‐Smit, R. ten Cate, Esther P A H Hoppenreijs, Femke H. M. Prince, G Hennemann, Marion A. J. van Rossum, T.J. Visser, T. J. Visser, R. Docter and Janneke Anink and has published in prestigious journals such as Science, The Lancet and JAMA.

In The Last Decade

M.H. Otten

40 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.H. Otten Netherlands 18 521 302 259 251 171 42 1.1k
Corina Hartman Israel 24 108 0.2× 591 2.0× 59 0.2× 575 2.3× 64 0.4× 74 2.3k
Visa Honkanen Finland 19 598 1.1× 135 0.4× 235 0.9× 399 1.6× 396 2.3× 44 1.3k
Michel Tsimaratos France 22 200 0.4× 550 1.8× 20 0.1× 202 0.8× 103 0.6× 67 1.7k
Fránco Cerutti Italy 19 68 0.1× 240 0.8× 20 0.1× 491 2.0× 35 0.2× 39 1.3k
Amira Al‐Uzri United States 15 98 0.2× 112 0.4× 187 0.7× 191 0.8× 19 0.1× 53 998
Gordon W. Moran United Kingdom 21 56 0.1× 157 0.5× 19 0.1× 536 2.1× 63 0.4× 96 1.5k
Barbara Głowińska‐Olszewska Poland 17 61 0.1× 127 0.4× 28 0.1× 290 1.2× 34 0.2× 101 1.2k
Dietrich Michalk Germany 21 56 0.1× 184 0.6× 28 0.1× 168 0.7× 42 0.2× 65 1.1k
Jon Kristinsson Norway 22 56 0.1× 139 0.5× 32 0.1× 1.2k 4.7× 25 0.1× 65 1.7k
Andrew S. Brem United States 24 36 0.1× 372 1.2× 37 0.1× 378 1.5× 38 0.2× 83 1.5k

Countries citing papers authored by M.H. Otten

Since Specialization
Citations

This map shows the geographic impact of M.H. Otten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.H. Otten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.H. Otten more than expected).

Fields of papers citing papers by M.H. Otten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.H. Otten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.H. Otten. The network helps show where M.H. Otten may publish in the future.

Co-authorship network of co-authors of M.H. Otten

This figure shows the co-authorship network connecting the top 25 collaborators of M.H. Otten. A scholar is included among the top collaborators of M.H. Otten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.H. Otten. M.H. Otten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woensel, Job B. M. van, Johannes B. van Goudoever, M.H. Otten, et al.. (2023). Structured Multidisciplinary Follow-Up After Pediatric Intensive Care: A Model for Continuous Data-Driven Health Care Innovation. Pediatric Critical Care Medicine. 24(6). 484–498. 9 indexed citations
2.
Otten, M.H., et al.. (2022). Long Stay and Frequent Readmission in the Pediatric Intensive Care in The Netherlands; 15-Year Time Trends. Critical Care Explorations. 4(12). e0798–e0798. 5 indexed citations
3.
Reinout, A., Katrien Oude Rengerink, M.H. Otten, et al.. (2021). Burden of respiratory syncytial virus bronchiolitis on the Dutch pediatric intensive care units. European Journal of Pediatrics. 180(10). 3141–3149. 21 indexed citations
4.
Anink, Janneke, Lisette W. A. van Suijlekom‐Smit, M.H. Otten, et al.. (2015). MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis. Arthritis Research & Therapy. 17(1). 200–200. 58 indexed citations
5.
6.
Otten, M.H., Janneke Anink, Femke H. M. Prince, et al.. (2014). Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register. Annals of the Rheumatic Diseases. 74(7). 1379–1386. 36 indexed citations
7.
Holzinger, Dirk, Michael Frosch, Femke H. M. Prince, et al.. (2012). The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis. Annals of the Rheumatic Diseases. 71(6). 974–980. 117 indexed citations
8.
Otten, M.H., Janneke Anink, Sandra Spronk, & Lisette W. A. van Suijlekom‐Smit. (2012). Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons. Annals of the Rheumatic Diseases. 72(11). 1806–1812. 39 indexed citations
9.
Faber, Joyce, Ute Fiedler, Melanie Avlar, et al.. (2012). Rapid EPA and DHA incorporation and reduced PGE2 levels after one week intervention with a medical food in cancer patients receiving radiotherapy, a randomized trial. Clinical Nutrition. 32(3). 338–345. 33 indexed citations
10.
Otten, M.H., Femke H. M. Prince, Janneke Anink, et al.. (2012). Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register. Annals of the Rheumatic Diseases. 72(5). 721–727. 40 indexed citations
11.
Anink, Janneke, M.H. Otten, Femke H. M. Prince, et al.. (2012). Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register. Lara D. Veeken. 52(4). 712–717. 11 indexed citations
12.
Otten, M.H., Femke H. M. Prince, Marinka Twilt, et al.. (2011). Tumor Necrosis Factor-blocking Agents for Children with Enthesitis-related Arthritis — Data from the Dutch Arthritis and Biologicals in Children Register, 1999–2010. The Journal of Rheumatology. 38(10). 2258–2263. 54 indexed citations
13.
Otten, M.H., François Prince, R. ten Cate, et al.. (2010). Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective?. Annals of the Rheumatic Diseases. 70(2). 337–340. 16 indexed citations
14.
Prince, François, M.H. Otten, & Lisette W. A. van Suijlekom‐Smit. (2010). Diagnosis and management of juvenile idiopathic arthritis. BMJ. 341(dec03 2). c6434–c6434. 47 indexed citations
15.
Otten, M.H., Femke H. M. Prince, Marinka Twilt, et al.. (2010). Delayed Clinical Response in Patients with Juvenile Idiopathic Arthritis Treated with Etanercept. The Journal of Rheumatology. 37(3). 665–667. 6 indexed citations
16.
17.
18.
Geldof, Han, et al.. (1993). Two different dose regimens of cisapride in the treatment of reflux oesophagitis: a double‐blind comparison with ranitidine. Alimentary Pharmacology & Therapeutics. 7(4). 409–415. 38 indexed citations
19.
Otten, M.H.. (1983). Iodothyronine sulfatase activity of two anaerobic bacterial strains from rat intestinal microflora. FEMS Microbiology Letters. 18(1-2). 75–77.
20.
Otten, M.H., et al.. (1978). Isolation and sedimentation analysis of RNA from Entamoeba histolytica.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 9 Suppl 1. 121–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Corina Hartman Breakdown of academic impact, for papers by Visa Honkanen Breakdown of academic impact, for papers by Michel Tsimaratos Breakdown of academic impact, for papers by Fránco Cerutti Breakdown of academic impact, for papers by Amira Al‐Uzri Breakdown of academic impact, for papers by Gordon W. Moran Breakdown of academic impact, for papers by Barbara Głowińska‐Olszewska Breakdown of academic impact, for papers by Dietrich Michalk Breakdown of academic impact, for papers by Jon Kristinsson Breakdown of academic impact, for papers by Andrew S. Brem
Rankless by CCL
2026